Michael S. Kostapanos

Author

Also Known As

E. Orenes-Pinero, M KOSTAPANOS, M Kostapanos, M S Kostapanos, M. Kostapanos, M. S. Kostapanos, M.S. Kostapanos, Michael Kostapanos, Michael S Kostapanos, Michael S. Kostapanos

133

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

University of Ioannina The Royal Free Hospital University College London National and Kapodistrian University of Athens

About

Michael S. Kostapanos is an author at University of Ioannina specializing in medicine, cardiovascular disease, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	420
2	Public Health	8	8	142
3	Diabetes	7	7	158
4	Health Sciences	6	6	163
5	Biochemistry	1	1	14

Michael S. Kostapanos

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Differential Effect of Hypolipidemic Drugs on Lipoprotein-Associated Phospholipase A <sub>2</sub> Vasilios G. Saougos, Afroditi P. Tambaki, M. Kalogirou, Arteriosclerosis Thrombosis and Vascular Biology	2007	121
Treating to target patients with primary hyperlipidaemia:comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study) Haralampos J. Milionis, Evangelos C. Rizos, Michael S. Kostapanos, Current Medical Research and Opinion	2006	75
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance Elisavet Moutzouri, Evangelos Liberopoulos, Dimitri P. Mikhailidis, International Journal of Clinical Practice	2011	73
Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose Michael S. Kostapanos, Haralambos Milionis, Aris P. Agouridis, International Journal of Clinical Practice	2009	54
The impact of the metabolic syndrome on health-related quality of life: a cross-sectional study in Greece D. Tziallas, Catherine Kastanioti, Michael S. Kostapanos, European Journal of Cardiovascular Nursing	2011	53
A 12-Week, Prospective, Open-Label Analysis of the Effect of Rosuvastatin on Triglyceride-Rich Lipoprotein Metabolism in Patients with Primary Dyslipidemia Michael S. Kostapanos, Haralampos J. Milionis, Theodosios D. Filippatos, Clinical Therapeutics Metabolic SyndromeCardiovascular DiseaseOpen-label AnalysisMedicineTriglyceride-rich Lipoprotein Metabolism	2007	52
The effects of orlistat and fenofibrate, alone or in combination, on high‐density lipoprotein subfractions and pre‐beta1‐HDL levels in obese patients with metabolic syndrome Theodosios D. Filippatos, Evangelos Liberopoulos, Michael S. Kostapanos, Diabetes Obesity and Metabolism	2007	51
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: A 24-week, randomized, open-label, prospective study Christos V. Rizos, Haralampos Milionis, Michael S. Kostapanos, Clinical Therapeutics Greek AdultsMetabolic SyndromeHypertensionDiabetes ManagementGlucose Metabolism	2010	50
Statin Pleiotropy Against Renal Injury Michael S. Kostapanos, Evangelos Liberopoulos, Moses Elisaf Journal of the CardioMetabolic Syndrome Renal InflammatoryRenal PathologyImmunologyRenal InflammationCell Death	2009	40
Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects Haralampos Milionis, Michael S. Kostapanos, Evangelos Liberopoulos, International Journal of Clinical Practice	2007	36

Page 1